Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Pre-market Movers » 08:54
02/02/23
02/02
08:54
02/02/23
08:54
FDX

FedEx

$202.08 /

+8.21 (+4.23%)

, BMY

Bristol-Myers

$71.22 /

-1.43 (-1.97%)

, HSY

Hershey

$225.25 /

+0.78 (+0.35%)

, HOG

Harley-Davidson

$46.78 /

+0.74 (+1.61%)

, META

Meta Platforms

$153.10 /

+4.135 (+2.78%)

, ALGN

Align Technology

$282.22 /

+12.72 (+4.72%)

, LLY

Eli Lilly

$342.49 /

-1.61 (-0.47%)

, MRK

Merck

$106.94 /

-0.48 (-0.45%)

, HON

Honeywell

$206.67 /

-1.87 (-0.90%)

, EL

Estee Lauder

$280.46 /

+3.53 (+1.27%)

, SIRI

Sirius XM

$5.84 /

+0.06 (+1.04%)

, DGX

Quest Diagnostics

$148.64 /

+0.035 (+0.02%)

, PENN

Penn Entertainment

$35.82 /

+0.385 (+1.09%)

, QRVO

Qorvo

$113.56 /

+4.91 (+4.52%)

Check out this morning's…

ShowHide Related Items >><<
SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

QRVO Qorvo
$113.56 /

+4.91 (+4.52%)

PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

META Meta Platforms
$153.10 /

+4.135 (+2.78%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

HOG Harley-Davidson
$46.78 /

+0.74 (+1.61%)

FDX FedEx
$202.08 /

+8.21 (+4.23%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

ALGN Align Technology
$282.22 /

+12.72 (+4.72%)

FDX FedEx
$202.08 /

+8.21 (+4.23%)

06:20 Today BofA
FedEx upgraded to Buy from Neutral at BofA
06:04 Today BofA
FedEx upgraded to Buy from Neutral at BofA
04:32 Today Citi
FedEx upgraded to Buy from Neutral at Citi
02/01/23 Morgan Stanley
Buy with Prime could be $3.5B-plus EBIT business for Amazon, says Morgan Stanley
BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/17/23 Cantor Fitzgerald
Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
12/23/22 William Blair
NccRCC 'material expansion opportunity' for Exelixis, says William Blair
11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
HSY Hershey
$225.25 /

+0.78 (+0.35%)

01/06/23 Evercore ISI
Hershey downgraded to In Line from Outperform at Evercore ISI
01/03/23 Wells Fargo
Hershey initiated with an Underweight at Wells Fargo
12/20/22 Morgan Stanley
Hershey price target raised to $231 from $224 at Morgan Stanley
12/08/22 UBS
Hershey upgraded to Buy from Neutral at UBS
HOG Harley-Davidson
$46.78 /

+0.74 (+1.61%)

12/22/22 DA Davidson
Harley-Davidson price target raised to $44 from $42 at DA Davidson
11/15/22 Jefferies
Harley-Davidson initiated with an Underperform at Jefferies
10/27/22 DA Davidson
Harley-Davidson price target raised to $42 from $36 at DA Davidson
10/27/22 Baird
Harley-Davidson price target raised to $48 from $45 at Baird
META Meta Platforms
$153.10 /

+4.135 (+2.78%)

08:45 Today RBC Capital
Meta Platforms price target raised to $225 from $160 at RBC Capital
08:30 Today Needham
Meta Platforms reported fundamentals still deteriorating, says Needham
08:25 Today Jefferies
Meta Platforms price target raised to $225 from $175 at Jefferies
08:12 Today Guggenheim
Meta Platforms price target raised to $210 from $130 at Guggenheim
ALGN Align Technology
$282.22 /

+12.72 (+4.72%)

07:44 Today Stifel
Align Technology price target raised to $375 from $265 at Stifel
07:04 Today Goldman Sachs
Goldman ups Align Technology to Neutral on more confidence in near-term demand
07:00 Today Goldman Sachs
Align Technology upgraded to Neutral from Sell at Goldman Sachs
06:50 Today Baird
Align Technology price target raised to $335 from $260 at Baird
LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

01/20/23 William Blair
Donanemab CRL a 'positive headline' for Biogen's Leqembi, says William Blair
01/12/23 Guggenheim
Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks
01/03/23 Barclays
Eli Lilly price target raised to $400 from $395 at Barclays
12/23/22 Raymond James
ProQR Therapeutics price target raised to $5 from $2 at Raymond James
MRK Merck
$106.94 /

-0.48 (-0.45%)

01/26/23 Citi
Novartis downgraded to Neutral from Buy at Citi
01/04/23 BofA
Merck upgraded to Buy at BofA on consistent revenue upside
01/04/23 BofA
Merck upgraded to Buy from Neutral at BofA
01/03/23 Wells Fargo
Merck price target raised to $125 from $110 at Wells Fargo
HON Honeywell
$206.67 /

-1.87 (-0.90%)

01/04/23 UBS
Honeywell downgraded to Sell from Buy at UBS
12/09/22 Citi
Honeywell price target raised to $248 from $213 at Citi
12/05/22 Deutsche Bank
Honeywell price target raised to $242 from $227 at Deutsche Bank
12/01/22 Barclays
Honeywell price target raised to $229 from $212 at Barclays
EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

01/31/23 Jefferies
Bath & Body Works price target raised to $52 from $45 at Jefferies
01/24/23 Stifel
Estee Lauder price target raised to $295 from $255 at Stifel
01/23/23 Deutsche Bank
Estee Lauder price target raised to $290 from $266 at Deutsche Bank
01/17/23 Oppenheimer
Estee Lauder price target raised to $300 from $245 at Oppenheimer
SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

01/03/23 JPMorgan
Sirius estimates cut on 'challenged' advertising market at JPMorgan
12/01/22 Citi
Sirius XM downgraded to Sell from Buy at Citi
11/02/22 Deutsche Bank
Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank
11/02/22 Pivotal Research
Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research
DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

01/23/23 Evercore ISI
Quest Diagnostics initiated with an In Line at Evercore ISI
01/12/23 Baird
Quest Diagnostics price target raised to $154 from $143 at Baird
12/14/22 Mizuho
Quest Diagnostics price target raised to $165 from $160 at Mizuho
11/17/22 Citi
Quest Diagnostics downgraded to Sell from Neutral at Citi
PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

01/20/23 JMP Securities
Penn Entertainment price target lowered to $45 from $48 at JMP Securities
01/11/23 Truist
Penn Entertainment price target lowered to $36 from $40 at Truist
01/09/23 Jefferies
Penn Entertainment downgraded to Hold at Jefferies as focus narrows
01/09/23 Jefferies
Penn Entertainment downgraded to Hold from Buy at Jefferies
QRVO Qorvo
$113.56 /

+4.91 (+4.52%)

08:50 Today Craig-Hallum
Qorvo price target raised to $130 from $120 at Craig-Hallum
07:37 Today BMO Capital
Qorvo price target raised to $105 from $90 at BMO Capital
07:28 Today Cowen
Qorvo price target raised to $100 from $80 at Cowen
07:24 Today Morgan Stanley
Qorvo price target raised to $110 from $87 at Morgan Stanley
SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

QRVO Qorvo
$113.56 /

+4.91 (+4.52%)

PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

META Meta Platforms
$153.10 /

+4.135 (+2.78%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

HOG Harley-Davidson
$46.78 /

+0.74 (+1.61%)

FDX FedEx
$202.08 /

+8.21 (+4.23%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

ALGN Align Technology
$282.22 /

+12.72 (+4.72%)

SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

META Meta Platforms
$153.10 /

+4.135 (+2.78%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

FDX FedEx
$202.08 /

+8.21 (+4.23%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

QRVO Qorvo
$113.56 /

+4.91 (+4.52%)

PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

META Meta Platforms
$153.10 /

+4.135 (+2.78%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

HOG Harley-Davidson
$46.78 /

+0.74 (+1.61%)

FDX FedEx
$202.08 /

+8.21 (+4.23%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

ALGN Align Technology
$282.22 /

+12.72 (+4.72%)

SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

QRVO Qorvo
$113.56 /

+4.91 (+4.52%)

PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

META Meta Platforms
$153.10 /

+4.135 (+2.78%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

HOG Harley-Davidson
$46.78 /

+0.74 (+1.61%)

FDX FedEx
$202.08 /

+8.21 (+4.23%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

ALGN Align Technology
$282.22 /

+12.72 (+4.72%)

Hot Stocks
Exscientia announces 1st- in-human trial for Bristol-Myers in-licensed EXS4318 » 08:09
02/02/23
02/02
08:09
02/02/23
08:09
EXAI

Exscientia

$8.02 /

+0.955 (+13.53%)

, BMY

Bristol-Myers

$71.22 /

-1.43 (-1.97%)

Exscientia (EXAI)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXAI Exscientia
$8.02 /

+0.955 (+13.53%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

EXAI Exscientia
$8.02 /

+0.955 (+13.53%)

11/16/22 Barclays
Exscientia price target lowered to $12 from $40 at Barclays
BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/17/23 Cantor Fitzgerald
Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
12/23/22 William Blair
NccRCC 'material expansion opportunity' for Exelixis, says William Blair
11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

Earnings
Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00 » 07:03
02/02/23
02/02
07:03
02/02/23
07:03
BMY

Bristol-Myers

$71.22 /

-1.43 (-1.97%)

FY23 total revenues are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/17/23 Cantor Fitzgerald
Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
12/23/22 William Blair
NccRCC 'material expansion opportunity' for Exelixis, says William Blair
11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

Earnings
Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72 » 07:02
02/02/23
02/02
07:02
02/02/23
07:02
BMY

Bristol-Myers

$71.22 /

-1.43 (-1.97%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/17/23 Cantor Fitzgerald
Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
12/23/22 William Blair
NccRCC 'material expansion opportunity' for Exelixis, says William Blair
11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

Yesterday
Earnings
Notable companies reporting before tomorrow's open » 20:25
02/01/23
02/01
20:25
02/01/23
20:25
LLY

Eli Lilly

$342.49 /

-1.61 (-0.47%)

, MRK

Merck

$106.94 /

-0.48 (-0.45%)

, BMY

Bristol-Myers

$71.22 /

-1.43 (-1.97%)

, HON

Honeywell

$206.67 /

-1.87 (-0.90%)

, EL

Estee Lauder

$280.46 /

+3.53 (+1.27%)

, HSY

Hershey

$225.25 /

+0.78 (+0.35%)

, SIRI

Sirius XM

$5.84 /

+0.06 (+1.04%)

, CAH

Cardinal Health

$75.71 /

-1.56 (-2.02%)

, DGX

Quest Diagnostics

$148.64 /

+0.035 (+0.02%)

, PENN

Penn Entertainment

$35.82 /

+0.385 (+1.09%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Eli Lilly (LLY), consensus $1.81... Merck (MRK), consensus $1.54... Bristol-Myers (BMY), consensus $1.72... Honeywell (HON), consensus $2.51... Estee Lauder (EL), consensus $1.30... Hershey (HSY), consensus $1.77... Sirius XM (SIRI), consensus 8c... Cardinal Health (CAH), consensus $1.14... Quest Diagnostics (DGX), consensus $1.91... Harley-Davidson (HOG), consensus 6c... Penn Entertaiment (PENN), consensus 41c.

ShowHide Related Items >><<
SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

CAH Cardinal Health
$75.71 /

-1.56 (-2.02%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

01/20/23 William Blair
Donanemab CRL a 'positive headline' for Biogen's Leqembi, says William Blair
01/12/23 Guggenheim
Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks
01/03/23 Barclays
Eli Lilly price target raised to $400 from $395 at Barclays
12/23/22 Raymond James
ProQR Therapeutics price target raised to $5 from $2 at Raymond James
MRK Merck
$106.94 /

-0.48 (-0.45%)

01/26/23 Citi
Novartis downgraded to Neutral from Buy at Citi
01/04/23 BofA
Merck upgraded to Buy at BofA on consistent revenue upside
01/04/23 BofA
Merck upgraded to Buy from Neutral at BofA
01/03/23 Wells Fargo
Merck price target raised to $125 from $110 at Wells Fargo
BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/17/23 Cantor Fitzgerald
Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
12/23/22 William Blair
NccRCC 'material expansion opportunity' for Exelixis, says William Blair
11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
HON Honeywell
$206.67 /

-1.87 (-0.90%)

01/04/23 UBS
Honeywell downgraded to Sell from Buy at UBS
12/09/22 Citi
Honeywell price target raised to $248 from $213 at Citi
12/05/22 Deutsche Bank
Honeywell price target raised to $242 from $227 at Deutsche Bank
12/01/22 Barclays
Honeywell price target raised to $229 from $212 at Barclays
EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

01/31/23 Jefferies
Bath & Body Works price target raised to $52 from $45 at Jefferies
01/24/23 Stifel
Estee Lauder price target raised to $295 from $255 at Stifel
01/23/23 Deutsche Bank
Estee Lauder price target raised to $290 from $266 at Deutsche Bank
01/17/23 Oppenheimer
Estee Lauder price target raised to $300 from $245 at Oppenheimer
HSY Hershey
$225.25 /

+0.78 (+0.35%)

01/06/23 Evercore ISI
Hershey downgraded to In Line from Outperform at Evercore ISI
01/03/23 Wells Fargo
Hershey initiated with an Underweight at Wells Fargo
12/20/22 Morgan Stanley
Hershey price target raised to $231 from $224 at Morgan Stanley
12/08/22 UBS
Hershey upgraded to Buy from Neutral at UBS
SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

01/03/23 JPMorgan
Sirius estimates cut on 'challenged' advertising market at JPMorgan
12/01/22 Citi
Sirius XM downgraded to Sell from Buy at Citi
11/02/22 Deutsche Bank
Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank
11/02/22 Pivotal Research
Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research
CAH Cardinal Health
$75.71 /

-1.56 (-2.02%)

01/31/23 UBS
Cardinal Health price target raised to $91 from $78 at UBS
11/22/22 Credit Suisse
Cardinal Health price target raised to $79 from $64 at Credit Suisse
11/14/22 Mizuho
Cardinal Health price target raised to $74 from $66 at Mizuho
11/07/22 Baird
Cardinal Health price target raised to $82 from $74 at Baird
DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

01/23/23 Evercore ISI
Quest Diagnostics initiated with an In Line at Evercore ISI
01/12/23 Baird
Quest Diagnostics price target raised to $154 from $143 at Baird
12/14/22 Mizuho
Quest Diagnostics price target raised to $165 from $160 at Mizuho
11/17/22 Citi
Quest Diagnostics downgraded to Sell from Neutral at Citi
PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

01/20/23 JMP Securities
Penn Entertainment price target lowered to $45 from $48 at JMP Securities
01/11/23 Truist
Penn Entertainment price target lowered to $36 from $40 at Truist
01/09/23 Jefferies
Penn Entertainment downgraded to Hold at Jefferies as focus narrows
01/09/23 Jefferies
Penn Entertainment downgraded to Hold from Buy at Jefferies
SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

CAH Cardinal Health
$75.71 /

-1.56 (-2.02%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

CAH Cardinal Health
$75.71 /

-1.56 (-2.02%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

DGX Quest Diagnostics
$148.64 /

+0.035 (+0.02%)

CAH Cardinal Health
$75.71 /

-1.56 (-2.02%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

SIRI Sirius XM
$5.84 /

+0.06 (+1.04%)

PENN Penn Entertainment
$35.82 /

+0.385 (+1.09%)

MRK Merck
$106.94 /

-0.48 (-0.45%)

LLY Eli Lilly
$342.49 /

-1.61 (-0.47%)

HSY Hershey
$225.25 /

+0.78 (+0.35%)

HON Honeywell
$206.67 /

-1.87 (-0.90%)

EL Estee Lauder
$280.46 /

+3.53 (+1.27%)

CAH Cardinal Health
$75.71 /

-1.56 (-2.02%)

BMY Bristol-Myers
$71.22 /

-1.43 (-1.97%)

Earnings
Notable companies reporting before tomorrow's open » 13:50
02/01/23
02/01
13:50
02/01/23
13:50
LLY

Eli Lilly

$341.25 /

-2.85 (-0.83%)

, MRK

Merck

$106.88 /

-0.54 (-0.50%)

, BMY

Bristol-Myers

$71.21 /

-1.44 (-1.98%)

, HON

Honeywell

$205.59 /

-2.95 (-1.41%)

, EL

Estee Lauder

$276.61 /

-0.32 (-0.12%)

, HSY

Hershey

$224.88 /

+0.41 (+0.18%)

, SIRI

Sirius XM

$5.80 /

+0.015 (+0.26%)

, CAH

Cardinal Health

$75.82 /

-1.45 (-1.88%)

, DGX

Quest Diagnostics

$146.83 /

-1.77 (-1.19%)

, PENN

Penn Entertainment

$35.10 /

-0.335 (-0.95%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Eli Lilly (LLY), consensus $1.81... Merck (MRK), consensus $1.54... Bristol-Myers (BMY), consensus $1.72... Honeywell (HON), consensus $2.51... Estee Lauder (EL), consensus $1.30... Hershey (HSY), consensus $1.77... Sirius XM (SIRI), consensus 8c... Cardinal Health (CAH), consensus $1.14... Quest Diagnostics (DGX), consensus $1.91... Harley-Davidson (HOG), consensus 6c... Penn Entertaiment (PENN), consensus 41c.

ShowHide Related Items >><<
SIRI Sirius XM
$5.80 /

+0.015 (+0.26%)

PENN Penn Entertainment
$35.10 /

-0.335 (-0.95%)

MRK Merck
$106.88 /

-0.54 (-0.50%)

LLY Eli Lilly
$341.25 /

-2.85 (-0.83%)

HSY Hershey
$224.88 /

+0.41 (+0.18%)

HON Honeywell
$205.59 /

-2.95 (-1.41%)

EL Estee Lauder
$276.61 /

-0.32 (-0.12%)

DGX Quest Diagnostics
$146.83 /

-1.77 (-1.19%)

CAH Cardinal Health
$75.82 /

-1.45 (-1.88%)

BMY Bristol-Myers
$71.21 /

-1.44 (-1.98%)

LLY Eli Lilly
$341.25 /

-2.85 (-0.83%)

01/20/23 William Blair
Donanemab CRL a 'positive headline' for Biogen's Leqembi, says William Blair
01/12/23 Guggenheim
Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks
01/03/23 Barclays
Eli Lilly price target raised to $400 from $395 at Barclays
12/23/22 Raymond James
ProQR Therapeutics price target raised to $5 from $2 at Raymond James
MRK Merck
$106.88 /

-0.54 (-0.50%)

01/26/23 Citi
Novartis downgraded to Neutral from Buy at Citi
01/04/23 BofA
Merck upgraded to Buy at BofA on consistent revenue upside
01/04/23 BofA
Merck upgraded to Buy from Neutral at BofA
01/03/23 Wells Fargo
Merck price target raised to $125 from $110 at Wells Fargo
BMY Bristol-Myers
$71.21 /

-1.44 (-1.98%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/17/23 Cantor Fitzgerald
Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
12/23/22 William Blair
NccRCC 'material expansion opportunity' for Exelixis, says William Blair
11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
HON Honeywell
$205.59 /

-2.95 (-1.41%)

01/04/23 UBS
Honeywell downgraded to Sell from Buy at UBS
12/09/22 Citi
Honeywell price target raised to $248 from $213 at Citi
12/05/22 Deutsche Bank
Honeywell price target raised to $242 from $227 at Deutsche Bank
12/01/22 Barclays
Honeywell price target raised to $229 from $212 at Barclays
EL Estee Lauder
$276.61 /

-0.32 (-0.12%)

01/31/23 Jefferies
Bath & Body Works price target raised to $52 from $45 at Jefferies
01/24/23 Stifel
Estee Lauder price target raised to $295 from $255 at Stifel
01/23/23 Deutsche Bank
Estee Lauder price target raised to $290 from $266 at Deutsche Bank
01/17/23 Oppenheimer
Estee Lauder price target raised to $300 from $245 at Oppenheimer
HSY Hershey
$224.88 /

+0.41 (+0.18%)

01/06/23 Evercore ISI
Hershey downgraded to In Line from Outperform at Evercore ISI
01/03/23 Wells Fargo
Hershey initiated with an Underweight at Wells Fargo
12/20/22 Morgan Stanley
Hershey price target raised to $231 from $224 at Morgan Stanley
12/08/22 UBS
Hershey upgraded to Buy from Neutral at UBS
SIRI Sirius XM
$5.80 /

+0.015 (+0.26%)

01/03/23 JPMorgan
Sirius estimates cut on 'challenged' advertising market at JPMorgan
12/01/22 Citi
Sirius XM downgraded to Sell from Buy at Citi
11/02/22 Deutsche Bank
Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank
11/02/22 Pivotal Research
Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research
CAH Cardinal Health
$75.82 /

-1.45 (-1.88%)

01/31/23 UBS
Cardinal Health price target raised to $91 from $78 at UBS
11/22/22 Credit Suisse
Cardinal Health price target raised to $79 from $64 at Credit Suisse
11/14/22 Mizuho
Cardinal Health price target raised to $74 from $66 at Mizuho
11/07/22 Baird
Cardinal Health price target raised to $82 from $74 at Baird
DGX Quest Diagnostics
$146.83 /

-1.77 (-1.19%)

01/23/23 Evercore ISI
Quest Diagnostics initiated with an In Line at Evercore ISI
01/12/23 Baird
Quest Diagnostics price target raised to $154 from $143 at Baird
12/14/22 Mizuho
Quest Diagnostics price target raised to $165 from $160 at Mizuho
11/17/22 Citi
Quest Diagnostics downgraded to Sell from Neutral at Citi
PENN Penn Entertainment
$35.10 /

-0.335 (-0.95%)

01/20/23 JMP Securities
Penn Entertainment price target lowered to $45 from $48 at JMP Securities
01/11/23 Truist
Penn Entertainment price target lowered to $36 from $40 at Truist
01/09/23 Jefferies
Penn Entertainment downgraded to Hold at Jefferies as focus narrows
01/09/23 Jefferies
Penn Entertainment downgraded to Hold from Buy at Jefferies
SIRI Sirius XM
$5.80 /

+0.015 (+0.26%)

PENN Penn Entertainment
$35.10 /

-0.335 (-0.95%)

MRK Merck
$106.88 /

-0.54 (-0.50%)

LLY Eli Lilly
$341.25 /

-2.85 (-0.83%)

HSY Hershey
$224.88 /

+0.41 (+0.18%)

HON Honeywell
$205.59 /

-2.95 (-1.41%)

EL Estee Lauder
$276.61 /

-0.32 (-0.12%)

DGX Quest Diagnostics
$146.83 /

-1.77 (-1.19%)

CAH Cardinal Health
$75.82 /

-1.45 (-1.88%)

BMY Bristol-Myers
$71.21 /

-1.44 (-1.98%)

SIRI Sirius XM
$5.80 /

+0.015 (+0.26%)

MRK Merck
$106.88 /

-0.54 (-0.50%)

LLY Eli Lilly
$341.25 /

-2.85 (-0.83%)

HSY Hershey
$224.88 /

+0.41 (+0.18%)

HON Honeywell
$205.59 /

-2.95 (-1.41%)

EL Estee Lauder
$276.61 /

-0.32 (-0.12%)

DGX Quest Diagnostics
$146.83 /

-1.77 (-1.19%)

CAH Cardinal Health
$75.82 /

-1.45 (-1.88%)

BMY Bristol-Myers
$71.21 /

-1.44 (-1.98%)

SIRI Sirius XM
$5.80 /

+0.015 (+0.26%)

PENN Penn Entertainment
$35.10 /

-0.335 (-0.95%)

MRK Merck
$106.88 /

-0.54 (-0.50%)

LLY Eli Lilly
$341.25 /

-2.85 (-0.83%)

HSY Hershey
$224.88 /

+0.41 (+0.18%)

HON Honeywell
$205.59 /

-2.95 (-1.41%)

EL Estee Lauder
$276.61 /

-0.32 (-0.12%)

DGX Quest Diagnostics
$146.83 /

-1.77 (-1.19%)

CAH Cardinal Health
$75.82 /

-1.45 (-1.88%)

BMY Bristol-Myers
$71.21 /

-1.44 (-1.98%)

SIRI Sirius XM
$5.80 /

+0.015 (+0.26%)

PENN Penn Entertainment
$35.10 /

-0.335 (-0.95%)

MRK Merck
$106.88 /

-0.54 (-0.50%)

LLY Eli Lilly
$341.25 /

-2.85 (-0.83%)

HSY Hershey
$224.88 /

+0.41 (+0.18%)

HON Honeywell
$205.59 /

-2.95 (-1.41%)

EL Estee Lauder
$276.61 /

-0.32 (-0.12%)

CAH Cardinal Health
$75.82 /

-1.45 (-1.88%)

BMY Bristol-Myers
$71.21 /

-1.44 (-1.98%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:03
02/01/23
02/01
10:03
02/01/23
10:03
FL

Foot Locker

$44.41 /

+0.91 (+2.09%)

, NKE

Nike

$127.22 /

-0.115 (-0.09%)

, TRU

TransUnion

$72.77 /

+1.02 (+1.42%)

, HUBB

Hubbell

$231.59 /

+2.52 (+1.10%)

, NEO

NeoGenomics

$12.45 /

+0.57 (+4.80%)

, LX

LexinFintech

$3.75 /

+0.425 (+12.80%)

, FINV

FinVolution Group

$5.82 /

+0.33 (+6.01%)

, AMD

AMD

$79.97 /

+4.78 (+6.36%)

, EA

Electronic Arts

$113.09 /

-15.4 (-11.99%)

, SNAP

Snap

$9.94 /

-1.605 (-13.91%)

, AAPL

Apple

$142.77 /

-1.5 (-1.04%)

, FNKO

Funko

$11.64 /

-0.475 (-3.92%)

, HAS

Hasbro

$58.94 /

-0.285 (-0.48%)

, SHOP

Shopify

$49.36 /

+0.085 (+0.17%)

, GIS

General Mills

$78.11 /

-0.24 (-0.31%)

, MAT

Mattel

$20.55 /

+0.1 (+0.49%)

, RCKT

Rocket Pharmaceuticals

$21.66 /

-0.06 (-0.28%)

, BEAM

Beam Therapeutics

$43.81 /

+0.35 (+0.81%)

Institutional investors…

ShowHide Related Items >><<
TRU TransUnion
$72.77 /

+1.02 (+1.42%)

SNAP Snap
$9.94 /

-1.605 (-13.91%)

SHOP Shopify
$49.36 /

+0.085 (+0.17%)

RCKT Rocket Pharmaceuticals
$21.66 /

-0.06 (-0.28%)

NKE Nike
$127.22 /

-0.115 (-0.09%)

NEO NeoGenomics
$12.45 /

+0.57 (+4.80%)

MAT Mattel
$20.55 /

+0.1 (+0.49%)

LX LexinFintech
$3.75 /

+0.425 (+12.80%)

HUBB Hubbell
$231.59 /

+2.52 (+1.10%)

HAS Hasbro
$58.94 /

-0.285 (-0.48%)

GIS General Mills
$78.11 /

-0.24 (-0.31%)

FNKO Funko
$11.64 /

-0.475 (-3.92%)

FL Foot Locker
$44.41 /

+0.91 (+2.09%)

FINV FinVolution Group
$5.82 /

+0.33 (+6.01%)

EA Electronic Arts
$113.09 /

-15.4 (-11.99%)

BEAM Beam Therapeutics
$43.81 /

+0.35 (+0.81%)

AMD AMD
$79.97 /

+4.78 (+6.36%)

AAPL Apple
$142.77 /

-1.5 (-1.04%)

FL Foot Locker
$44.41 /

+0.91 (+2.09%)

02/01/23 Credit Suisse
Foot Locker upgraded to Outperform from Neutral at Credit Suisse
11/28/22 Goldman Sachs
Goldman finds small crowds, more promotions over Black Friday weekend
11/21/22 Barclays
Foot Locker price target raised to $40 from $38 at Barclays
11/21/22 Deutsche Bank
Foot Locker price target raised to $36 from $31 at Deutsche Bank
NKE Nike
$127.22 /

-0.115 (-0.09%)

01/26/23 Wells Fargo
Nike price target raised to $146 from $135 at Wells Fargo
01/26/23 JPMorgan
Nike price target raised to $156 from $128 at JPMorgan
01/23/23 Cowen
Skechers upgraded to Outperform at Cowen on momentum and margin recovery
TRU TransUnion
$72.77 /

+1.02 (+1.42%)

02/01/23 BofA
TransUnion upgraded to Buy from Neutral at BofA
01/13/23 Wells Fargo
TransUnion upgraded to Overweight from Equal Weight at Wells Fargo
01/13/23 Wells Fargo
TransUnion upgraded to Overweight from Equal Weight at Wells Fargo
01/06/23 Exane BNP Paribas
TransUnion initiated with a Neutral at Exane BNP Paribas
HUBB Hubbell
$231.59 /

+2.52 (+1.10%)

02/01/23 JPMorgan
Hubbell upgraded to Neutral following de-rating at JPMorgan
02/01/23 JPMorgan
Hubbell upgraded to Neutral from Underweight at JPMorgan
01/04/23 UBS
Hubbell downgraded to Sell from Neutral at UBS
12/28/22 Stephens
Stephens carries over seven stocks to 'Best Ideas' list for 2023
NEO NeoGenomics
$12.45 /

+0.57 (+4.80%)

02/01/23 Needham
Needham upgrades NeoGenomics to Buy amid revenue and margin growth
02/01/23 Needham
NeoGenomics upgraded to Buy from Hold at Needham
11/14/22 Piper Sandler
NeoGenomics price target lowered to $18 from $19 at Piper Sandler
08/26/22 Benchmark
NeoGenomics downgraded to Hold from Buy at Benchmark
LX LexinFintech
$3.75 /

+0.425 (+12.80%)

02/01/23 UBS
UBS upgrades 'second-tier players' LexinFintech, FinVolution to Buy
02/01/23 UBS
LexinFintech upgraded to Buy from Neutral at UBS
11/14/22 CLSA
LexinFintech upgraded to Accumulate from Reduce at CLSA
06/01/22 CLSA
LexinFintech downgraded to Sell from Outperform at CLSA
FINV FinVolution Group
$5.82 /

+0.33 (+6.01%)

02/01/23 UBS
FinVolution Group upgraded to Buy from Neutral at UBS
09/29/22 China Renaissance
FinVolution Group assumed with a Buy at China Renaissance
08/24/22 Citi
FinVolution Group price target raised to $5.68 from $5.33 at Citi
AMD AMD
$79.97 /

+4.78 (+6.36%)

02/01/23 Craig-Hallum
Craig-Hallum downgrades AMD to Hold on slowing growth
02/01/23 Northland
AMD guidance 'isn't great,' but 'not a disaster,' says Northland
02/01/23 Craig-Hallum
AMD downgraded to Hold from Buy at Craig-Hallum
02/01/23 Morgan Stanley
AMD's softer outlook 'still could be a relief' after Intel, says Morgan Stanley
EA Electronic Arts
$113.09 /

-15.4 (-11.99%)

02/01/23 BofA
Electronic Arts downgraded to Neutral at BofA on lower growth outlook
02/01/23 BofA
Electronic Arts downgraded to Neutral from Buy at BofA
02/01/23 Wells Fargo
Electronic Arts price target lowered to $120 from $150 at Wells Fargo
02/01/23 Roth MKM
Electronic Arts price target lowered to $112 from $131 at Roth Capital
SNAP Snap
$9.94 /

-1.605 (-13.91%)

02/01/23 Truist
Snap price target lowered to $8 from $10 at Truist
02/01/23 Rosenblatt
Snap price target raised to $10 from $8 at Rosenblatt
02/01/23 Canaccord
Snap price target lowered to $11 from $12 at Canaccord
02/01/23 Benchmark
Benchmark downgrades 'too far behind' Snap to Hold after earnings
AAPL Apple
$142.77 /

-1.5 (-1.04%)

01/31/23 UBS
Apple iPhone sell-through down 12% in Q4, says UBS
01/30/23 Wells Fargo
Wells Fargo near-term cautious on Apple into upcoming Q1 earnings
01/30/23 Credit Suisse
Credit Suisse remains bullish on Apple, sees potential upside to estimates
FNKO Funko
$11.64 /

-0.475 (-3.92%)

01/31/23 Goldman Sachs
Goldman assumes Funko, downgrades to Sell on execution risk
01/31/23 Goldman Sachs
Funko downgraded to Sell from Neutral at Goldman Sachs
01/12/23 Jefferies
Funko downgraded to Hold from Buy at Jefferies
01/04/23 BMO Capital
Funko likely had 'decent holiday', says BMO Capital
HAS Hasbro
$58.94 /

-0.285 (-0.48%)

01/31/23 Goldman Sachs
Hasbro assumed with Neutral from Buy at Goldman Sachs
01/27/23 BMO Capital
Hasbro pre-announcement neither shocking nor surprising, says BMO Capital
01/27/23 MKM Partners
Hasbro price target lowered to $74 from $80 at MKM Partners
01/27/23 DA Davidson
Hasbro price target lowered to $95 from $113 at DA Davidson
SHOP Shopify
$49.36 /

+0.085 (+0.17%)

02/01/23 Scotiabank
Scotiabank starts Shopify at Sector Perform on 'robust' valuation
02/01/23 Morgan Stanley
Buy with Prime could be $3.5B-plus EBIT business for Amazon, says Morgan Stanley
01/31/23 Scotiabank
Shopify initiated with a Sector Perform at Scotiabank
01/30/23 UBS
Amazon's Buy with Prime puts up to 14% of Shopify revenue at risk, says UBS
GIS General Mills
$78.11 /

-0.24 (-0.31%)

02/01/23 Stifel
Stifel not surprised by potential competitive entrant from Blue Buffalo
02/01/23 Mizuho
General Mills initiated with a Neutral at Mizuho
01/26/23 UBS
General Mills upgraded to Buy from Neutral at UBS
01/03/23 Wells Fargo
General Mills initiated with an Equal Weight at Wells Fargo
MAT Mattel
$20.55 /

+0.1 (+0.49%)

01/31/23 Goldman Sachs
Mattel assumed with a Buy at Goldman Sachs
10/26/22 DA Davidson
Mattel price target lowered to $31 from $45 at DA Davidson
10/13/22 Jefferies
Mattel price target lowered to $22, transferred with a Hold at Jefferies
10/05/22 Stifel
Hasbro price target lowered to $84 from $99 at Stifel
RCKT Rocket Pharmaceuticals
$21.66 /

-0.06 (-0.28%)

02/01/23 Morgan Stanley
Rocket Pharmaceuticals initiated with an Overweight at Morgan Stanley
12/23/22 BofA
Rocket Pharmaceuticals stock reaction looks 'overdone,' says BofA
12/22/22 William Blair
William Blair remains bullish on Rocket following FDA discussion commentary
12/22/22 UBS
Rocket Pharmaceuticals weakness a buying opportunity, says UBS
BEAM Beam Therapeutics
$43.81 /

+0.35 (+0.81%)

02/01/23 Cantor Fitzgerald
Beam Therapeutics initiated with an Overweight at Cantor Fitzgerald
01/31/23 Cantor Fitzgerald
Beam Therapeutics initiated with an Overweight at Cantor Fitzgerald
12/20/22 BMO Capital
Beam Therapeutics upgraded to Outperform from Market Perform at BMO Capital
12/13/22 Citi
Beam Therapeutics initiated with a Buy at Citi
TRU TransUnion
$72.77 /

+1.02 (+1.42%)

SNAP Snap
$9.94 /

-1.605 (-13.91%)

SHOP Shopify
$49.36 /

+0.085 (+0.17%)

RCKT Rocket Pharmaceuticals
$21.66 /

-0.06 (-0.28%)

NKE Nike
$127.22 /

-0.115 (-0.09%)

NEO NeoGenomics
$12.45 /

+0.57 (+4.80%)

MAT Mattel
$20.55 /

+0.1 (+0.49%)

HUBB Hubbell
$231.59 /

+2.52 (+1.10%)

HAS Hasbro
$58.94 /

-0.285 (-0.48%)

GIS General Mills
$78.11 /

-0.24 (-0.31%)

FNKO Funko
$11.64 /

-0.475 (-3.92%)

FL Foot Locker
$44.41 /

+0.91 (+2.09%)

EA Electronic Arts
$113.09 /

-15.4 (-11.99%)

BEAM Beam Therapeutics
$43.81 /

+0.35 (+0.81%)

AMD AMD
$79.97 /

+4.78 (+6.36%)

AAPL Apple
$142.77 /

-1.5 (-1.04%)

  • 04
    Oct
TRU TransUnion
$72.77 /

+1.02 (+1.42%)

SNAP Snap
$9.94 /

-1.605 (-13.91%)

SHOP Shopify
$49.36 /

+0.085 (+0.17%)

NKE Nike
$127.22 /

-0.115 (-0.09%)

HAS Hasbro
$58.94 /

-0.285 (-0.48%)

GIS General Mills
$78.11 /

-0.24 (-0.31%)

FL Foot Locker
$44.41 /

+0.91 (+2.09%)

EA Electronic Arts
$113.09 /

-15.4 (-11.99%)

AMD AMD
$79.97 /

+4.78 (+6.36%)

AAPL Apple
$142.77 /

-1.5 (-1.04%)

TRU TransUnion
$72.77 /

+1.02 (+1.42%)

SNAP Snap
$9.94 /

-1.605 (-13.91%)

SHOP Shopify
$49.36 /

+0.085 (+0.17%)

RCKT Rocket Pharmaceuticals
$21.66 /

-0.06 (-0.28%)

NKE Nike
$127.22 /

-0.115 (-0.09%)

NEO NeoGenomics
$12.45 /

+0.57 (+4.80%)

MAT Mattel
$20.55 /

+0.1 (+0.49%)

HUBB Hubbell
$231.59 /

+2.52 (+1.10%)

HAS Hasbro
$58.94 /

-0.285 (-0.48%)

GIS General Mills
$78.11 /

-0.24 (-0.31%)

FNKO Funko
$11.64 /

-0.475 (-3.92%)

FL Foot Locker
$44.41 /

+0.91 (+2.09%)

EA Electronic Arts
$113.09 /

-15.4 (-11.99%)

BEAM Beam Therapeutics
$43.81 /

+0.35 (+0.81%)

AMD AMD
$79.97 /

+4.78 (+6.36%)

AAPL Apple
$142.77 /

-1.5 (-1.04%)

SNAP Snap
$9.94 /

-1.605 (-13.91%)

SHOP Shopify
$49.36 /

+0.085 (+0.17%)

NKE Nike
$127.22 /

-0.115 (-0.09%)

MAT Mattel
$20.55 /

+0.1 (+0.49%)

HAS Hasbro
$58.94 /

-0.285 (-0.48%)

GIS General Mills
$78.11 /

-0.24 (-0.31%)

FL Foot Locker
$44.41 /

+0.91 (+2.09%)

FINV FinVolution Group
$5.82 /

+0.33 (+6.01%)

EA Electronic Arts
$113.09 /

-15.4 (-11.99%)

AMD AMD
$79.97 /

+4.78 (+6.36%)

AAPL Apple
$142.77 /

-1.5 (-1.04%)

Upgrade
Needham upgrades NeoGenomics to Buy amid revenue and margin growth » 07:57
02/01/23
02/01
07:57
02/01/23
07:57
NEO

NeoGenomics

$11.89 /

+0.52 (+4.57%)

Needham analyst Mike…

Needham analyst Mike Matson upgraded NeoGenomics to Buy from Hold with a $15 price target. The analyst is "more encouraged" by NeoGenomics' revenue and margin growth in recent quarters amid changes to pricing and operational improvements. While management has indicated that 2023 RaDaR sales are not likely to be meaningful, the firm believes that if early adoption signs are encouraging, investor excitement could build heading into 2024.

ShowHide Related Items >><<
NEO NeoGenomics
$11.89 /

+0.52 (+4.57%)

NEO NeoGenomics
$11.89 /

+0.52 (+4.57%)

02/01/23 Needham
NeoGenomics upgraded to Buy from Hold at Needham
11/14/22 Piper Sandler
NeoGenomics price target lowered to $18 from $19 at Piper Sandler
08/26/22 Benchmark
NeoGenomics downgraded to Hold from Buy at Benchmark
08/22/22 Needham
Needham cuts NeoGenomics to Hold, sees 2023 as 'transition year'
NEO NeoGenomics
$11.89 /

+0.52 (+4.57%)

NEO NeoGenomics
$11.89 /

+0.52 (+4.57%)

Upgrade
NeoGenomics upgraded to Buy from Hold at Needham » 05:39
02/01/23
02/01
05:39
02/01/23
05:39
NEO

NeoGenomics

$11.89 /

+0.52 (+4.57%)

Needham analyst Mike…

Needham analyst Mike Matson upgraded NeoGenomics to Buy from Hold with a $15 price target.

ShowHide Related Items >><<
NEO NeoGenomics
$11.89 /

+0.52 (+4.57%)

NEO NeoGenomics
$11.89 /

+0.52 (+4.57%)

11/14/22 Piper Sandler
NeoGenomics price target lowered to $18 from $19 at Piper Sandler
08/26/22 Benchmark
NeoGenomics downgraded to Hold from Buy at Benchmark
08/22/22 Needham
Needham cuts NeoGenomics to Hold, sees 2023 as 'transition year'
08/22/22 Needham
NeoGenomics downgraded to Hold from Buy at Needham
NEO NeoGenomics
$11.89 /

+0.52 (+4.57%)

NEO NeoGenomics
$11.89 /

+0.52 (+4.57%)

Tuesday
Hot Stocks
Prothena reports 'positive' topline Phase 1 study results for PRX005 » 16:05
01/31/23
01/31
16:05
01/31/23
16:05
PRTA

Prothena

$56.23 /

+1.25 (+2.27%)

, BMY

Bristol-Myers

$72.48 /

+0.45 (+0.62%)

Prothena Corporation…

Prothena Corporation announced positive topline Phase 1 single ascending dose (SAD) study results for PRX005, a potentially best-in-class investigational tri-epitopic antibody for the treatment of Alzheimer's disease that specifically binds with high affinity to the R1, R2, and R3 repeats within the microtubule binding region (MTBR) of tau and targets both 3R and 4R tau isoforms. PRX005 is one of three programs in the global neuroscience research and development collaboration between Prothena and Bristol Myers Squibb. "For the first time, we have confirmation that PRX005 is safe and well-tolerated in humans and that it crosses the blood-brain barrier with robust central nervous system (CNS) penetration. We developed PRX005 to uniquely target a key region within the MTBR of tau to reduce pathogenic tau uptake into neurons, an attribute that has not been similarly achievable with antibodies targeting other regions of tau. These topline Phase 1 data, together with the mounting scientific evidence suggesting that tau propagation could be mediated by MTBR-tau seeds, underscores the potential of PRX005 in treating Alzheimer's disease," said Gene Kinney, PhD, President and Chief Executive Officer of Prothena. "Working closely with Bristol Myers Squibb, we are combining our expertise to advance the development of PRX005 as quickly as possible, and we look forward to seeing Phase 1 multiple ascending dose (MAD) results in patients with Alzheimer's disease later this year." In this first-in-human, randomized, placebo controlled, SAD study, healthy volunteers (n&#61;19) were enrolled into three PRX005 dose level cohorts (low, medium or high dose) and randomized in a 3:1 drug to placebo ratio. Study participants received a single dose of PRX0005 or placebo intravenously (IV) and were followed for up to two months. The results of the study found all three dose level cohorts of PRX005 to be generally safe and well tolerated, meeting the Phase 1 SAD study primary objective. None of the treatment emergent adverse events (TEAE) were serious. No clinically relevant changes were observed in other safety parameters. PRX005 also met key pharmacokinetic (PK) and immunogenicity secondary endpoints. Plasma drug concentrations of PRX005 increased in a dose-proportional manner. Furthermore, PRX005 exposure in cerebrospinal fluid (CSF) was measured in the high dose cohort and based on the robust exposure of PRX005 in the CSF (day 29 CSF:Plasma ratio&#61;0.2%), substantial target engagement is expected in the CNS. PRX005 had a desirable immunogenicity profile with no persistent PRX005-induced antidrug antibodies (ADAs) observed.

ShowHide Related Items >><<
PRTA Prothena
$56.23 /

+1.25 (+2.27%)

BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

PRTA Prothena
$56.23 /

+1.25 (+2.27%)

01/27/23 Piper Sandler
Prothena initiated with an Overweight at Piper Sandler
12/21/22 Cantor Fitzgerald
Prothena price target raised to $98 from $91 at Cantor Fitzgerald
11/29/22 Jefferies
Prothena data from AD/PD abstract 'promising,' says Jefferies
11/15/22 Oppenheimer
Prothena price target raised to $120 from $110 at Oppenheimer
BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/17/23 Cantor Fitzgerald
Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
12/23/22 William Blair
NccRCC 'material expansion opportunity' for Exelixis, says William Blair
11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
PRTA Prothena
$56.23 /

+1.25 (+2.27%)

BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

  • 15
    Dec
BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

PRTA Prothena
$56.23 /

+1.25 (+2.27%)

BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.